Skip to main content
Premium Trial:

Request an Annual Quote

Nobel, Shmobel

With scientific work becoming more and more collaborative, Adaptive Complexity's Michael White thinks that the Nobel prize may slip into obscurity. He argues that Nobel-level work today is carried out by more than three principal scientists (the prize can only be shared among three people) and that the prizes, particular in biology, are generally awarded long after the work was completed when the scientists are nearing retirement. "This is in stark contrast to many of the mid-20th century prizes, which were frequently awarded to people still very active in the field," White writes.

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.